Page last updated: 2024-09-02

l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide and oxidopamine

l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide has been researched along with oxidopamine in 4 studies

Compound Research Comparison

Studies
(l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide)
Trials
(l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide)
Recent Studies (post-2010)
(l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide)
Studies
(oxidopamine)
Trials
(oxidopamine)
Recent Studies (post-2010) (oxidopamine)
138728,63062,407

Protein Interaction Comparison

ProteinTaxonomyl-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide (IC50)oxidopamine (IC50)
Glyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)8
DNA repair protein RAD52 homologHomo sapiens (human)0.779

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kono, T; Makino, I; Nakamura, K; Sato, Y; Tamori, K; Yokohama, S; Yoneda, M1
Makino, I; Nakamura, K; Sato, Y; Terano, A; Yoneda, M1
Goto, M; Haneda, M; Hiraishi, H; Nakamura, K; Shimada, T; Terano, A; Yoneda, M1
Hiraishi, H; Kono, T; Nakamura, K; Shimada, T; Tamano, M; Watanobe, H; Yoneda, M1

Other Studies

4 other study(ies) available for l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide and oxidopamine

ArticleYear
Central thyrotropin-releasing hormone stimulates hepatic DNA synthesis in rats.
    Hepatology (Baltimore, Md.), 1997, Volume: 26, Issue:5

    Topics: Animals; Antibodies; Atropine; Brain; DNA; Injections, Intraventricular; Insulin; Liver; Male; Organ Size; Oxidopamine; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; Sympathectomy; Thyrotropin-Releasing Hormone; Vagotomy

1997
Protective effect of central thyrotropin-releasing hormone on carbon tetrachloride-induced acute hepatocellular necrosis in rats.
    Journal of hepatology, 2003, Volume: 39, Issue:1

    Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Atropine; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Enzyme Inhibitors; Indomethacin; Injections, Intraventricular; Liver; Liver Diseases; Male; Necrosis; NG-Nitroarginine Methyl Ester; Oxidopamine; Parasympatholytics; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; Sympatholytics; Thyrotropin-Releasing Hormone; Vagotomy

2003
Protective effect of central thyrotropin-releasing hormone analog on cerulein-induced acute pancreatitis in rats.
    Regulatory peptides, 2005, Feb-15, Volume: 125, Issue:1-3

    Topics: Adrenergic Agents; Amylases; Animals; Central Nervous System; Ceruletide; Dose-Response Relationship, Drug; Edema; Enzyme Inhibitors; Male; Neuropeptides; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidopamine; Pancreas; Pancreatitis; Peptides; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; Thyrotropin-Releasing Hormone; Time Factors

2005
Central thyrotropin-releasing hormone increases hepatic cyclic AMP through vagal-cholinergic and prostaglandin-dependent pathways in rats.
    Peptides, 2005, Volume: 26, Issue:9

    Topics: Animals; Atropine; Cell Proliferation; Cholinergic Fibers; Cyclic AMP; DNA; Dose-Response Relationship, Drug; Indomethacin; Injections, Intraventricular; Liver; Male; Oxidopamine; Prostaglandins; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; Signal Transduction; Thyrotropin-Releasing Hormone; Vagotomy; Vagus Nerve

2005